Cargando...
Recent advances in understanding and managing myasthenia gravis
Autoimmune myasthenia gravis (MG) is a neuromuscular junction disorder marked clinically by fatigable muscle weakness and serologically by the presence of autoantibodies against acetylcholine receptors (AChRs), muscle-specific kinase (MuSK), or lipoprotein-related protein 4 (LPR4). Over the past few...
Gardado en:
| Publicado en: | F1000Res |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
F1000 Research Limited
2018
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6213783/ https://ncbi.nlm.nih.gov/pubmed/30443340 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12688/f1000research.15973.1 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|